Risk prediction for clonal cytopenia: multicenter real-world evidence
Zhuoer Xie(Mayo Clinic), Aref Al‐Kali(Mayo Clinic), Afaf E.G. Osman(University of Utah), Andrew M. Brunner(Harvard University), Rami S. Komrokji(Moffitt Cancer Center), H. Joachim Deeg(Fred Hutch Cancer Center), Yasmin Abaza(Northwestern University), Catherine Lai(University of Pennsylvania), Hetty E. Carraway(Cleveland Clinic), Charlton Tsai(NewYork–Presbyterian Hospital), Sara Pozzi(University of Pavia), Catherine C. Coombs(Memorial Sloan Kettering Cancer Center), Cecilia Arana Yi(Mayo Clinic Hospital), Stephen S. Chung(Memorial Sloan Kettering Cancer Center), Chiara Elena(Policlinico San Matteo Fondazione), James M. Foran(Memorial Sloan Kettering Cancer Center), Anand Patel(Ascension), Joshua F. Zeidner(University of North Carolina at Chapel Hill), Eric Padron(Moffitt Cancer Center), Abhay Singh(Cleveland Clinic), Anna Gallì(University of Pavia), Monzr M. Al Malki(City of Hope), Michael R. Savona(Vanderbilt University), Namrata S. Chandhok(Sylvester Comprehensive Cancer Center), Elizabeth A. Griffiths(Roswell Park Comprehensive Cancer Center), Ashwin Kishtagari(Memorial Sloan Kettering Cancer Center), Shira Dinner(Dana-Farber Cancer Institute), Amer M. Zeidan(Yale Cancer Center), Mrinal M. Patnaik(Mayo Clinic), Luca Malcovati(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Pinkal Desai(NewYork–Presbyterian Hospital), Talha Badar(Mayo Clinic in Florida), Lourdes Mendez(Beth Israel Deaconess Medical Center), Deborah Soong(University of Miami), Idoroenyi Amanam(City Of Hope National Medical Center), Jan Philipp Bewersdorf(Memorial Sloan Kettering Cancer Center), Justin Taylor(Medical University of South Carolina), Yazan F. Madanat(The University of Texas Southwestern Medical Center), Alexandra Regelson(Mayo Clinic), Lionel Adès(Centre National de la Recherche Scientifique), Susan Geyer(University of South Florida), Caner Saygin(University of Illinois Chicago), Najla Al‐Ali(Moffitt Cancer Center), Jacqueline Ferrari(University of Pavia)
Cited by 51
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k